Aseel Alsouqi is a Hematology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 42 publications with 354 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
36%Statin12.8%Atorvastatin Calcium100%Part D<11 patientsACE inhibitor9.1%Lisinopril100%Part D<11 patients+ 2 more classes in this area
Respiratory
20.7%Corticosteroid11%Fluticasone Propionate100%Part D<11 patientsbeta2-Adrenergic Agonist9.8%Albuterol Sulfate Hfa100%Part D<11 patientsMetabolism & gastrointestinal
16.5%Proton pump inhibitor8.5%Omeprazole100%Part D<11 patientsBiguanide (metformin)7.9%Metformin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EXABS-126-CLL: Supportive Care in CLL Before, During, and After Therapy
Clinical Lymphoma Myeloma & Leukemia
2026 - CLL-991: Treatment Burden Among Patients Aged 75 Years or Older With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Clinical Lymphoma Myeloma & Leukemia
2026 - POSTER: CLL-991: Treatment Burden Among Patients Aged 75 Years or Older With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Clinical Lymphoma Myeloma & Leukemia
2026 - Olverembatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: Meta-analysis of efficacy and safety outcomes.
Journal of Clinical Oncology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Otterson, MD
The Ohio State University Comprehensive Cancer Center
Raphael Pollock, MD, PhD
The Ohio State University Comprehensive Cancer Center
Steven Clinton, MD
The Ohio State University Comprehensive Cancer Center
Claire Verschraegen, MD
The Ohio State University Comprehensive Cancer Center
Joseph Antin, MD
Harvard University
Scott Kaufmann, MD
Mayo Clinic College of Medicine
Jeffrey Miller, MD
University of Minnesota Medical School
Ruben Mesa, MD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”